Cardiomyopathies Clinical Trial
Official title:
Diagnosis of Fabry Disease: Impact of an Educational Brochure Intended for Cardiologist
The cardiac Fabry disease are early, frequent and severe, dominated by the frequency of left ventricular hypertrophy. They are responsible for a high morbidity and mortality, reducing life expectancy of 15 to 20 years for men. Fabry disease and heart attacks are still diagnosed late. This delay in diagnosis is due to the non-specificity of clinical, electrocardiographic and echocardiographic disease, but also by a certain ignorance of this pathology in the medical community. The importance of early diagnosis of Fabry disease and heart disease is well established: enzyme replacement therapy is most effective when instituted early, before the onset of irreversible damage such as fibrosis. With the blotter, we now have a simple and robust screening tool for Fabry disease, achievable consultation. Targeted educational interventions to physicians have shown their effectiveness in improving the screening and diagnosis of rare diseases. We offer a prospective observational type before / after study, which aims to assess the value of an educational brochure for cardiologists to improve the screening and diagnosis of Fabry disease in Normandy.
n/a
Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05428787 -
Resynchronization in Patients With HF in AF Trial Undergoing Pace & AVNA Strategy With LBBAP Compared With BiV Pacing
|
N/A | |
Not yet recruiting |
NCT05567445 -
Outcome of Cardiomyopathic Adults Admission in ICU.
|
||
Completed |
NCT02555527 -
Contrast Echocardiography Cost Effectiveness for Left Ventricular Thrombus Assessment
|
N/A | |
Completed |
NCT00371891 -
Ontario Multidetector Computed Tomographic (MDCT) Coronary Angiography Study (OMCAS)
|
Phase 4 | |
Recruiting |
NCT05552521 -
Diastolic Dysfunction in Septic Shock and Cardiomyopathy Genetic Variants
|
||
Recruiting |
NCT04166331 -
Adjunctive DobutAmine in sePtic Cardiomyopathy With Tissue Hypoperfusion
|
Phase 3 | |
Terminated |
NCT06331507 -
Refinement and Assessment of New MRI Technologies for Cardiovascular Exams Using the Phillips CMR Patch
|
N/A | |
Completed |
NCT01953523 -
Safety and Clinical Outcomes Study: SVF Deployment for Orthopedic, Neurologic, Urologic, and Cardio-pulmonary Conditions
|
N/A | |
Recruiting |
NCT04695119 -
Sepsis in the ICU-II
|
||
Completed |
NCT03228966 -
Ped HIV - Echo Study: Kenya
|
||
Not yet recruiting |
NCT06348732 -
Diagnostic and Prognostic Role of Troponin and Brain Natriuretic Peptide in Pediatric Patients With Cardiomyopathy in Correlation to Echocardiography Findings
|
||
Recruiting |
NCT05556369 -
Genetic Characterization of Cardiomyopathies (POLICARDIOMIO2021)
|
||
Recruiting |
NCT04520646 -
A Pilot Study of Empagliflozin in the Treatment of Acromegalic Cardiomyopathy
|
N/A | |
Not yet recruiting |
NCT03899298 -
Safety and Clinical Outcomes With Amniotic and Umbilical Cord Tissue Therapy for Numerous Medical Conditions
|
Phase 1 | |
Completed |
NCT04323852 -
Can Vitamin D Reduce Heart Muscle Damage After Bypass Surgery?
|
Phase 4 | |
Completed |
NCT03527381 -
Nitric Oxide in Cardiopulmonary Bypass for Renal Protection in Cardiac Surgery
|
Phase 1/Phase 2 | |
Withdrawn |
NCT02462213 -
Prospective Identification of Cardiac Amyloidosis by Cardiac Magnetic Resonance Imaging
|
N/A | |
Active, not recruiting |
NCT00418041 -
Chronic Heart Failure Analysis and Registry in the Tohoku District 2 (CHART-2 Study)
|
N/A | |
Not yet recruiting |
NCT06091475 -
Therapy to Maintain Remission in Dilated Cardiomyopathy
|
N/A | |
Recruiting |
NCT03317964 -
Genetic Basis of Pacing-induced Cardiomyopathy
|